What Do the Guidelines Really Say About Aspirin?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Texas Heart Institute journal - 45(2018), 4 vom: 29. Aug., Seite 228-230 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Millard, Michael A [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.12.2018 Date Revised 11.12.2018 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.14503/THIJ-18-6673 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM290079551 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM290079551 | ||
| 003 | DE-627 | ||
| 005 | 20231225063941.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.14503/THIJ-18-6673 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0966.xml |
| 035 | |a (DE-627)NLM290079551 | ||
| 035 | |a (NLM)30374231 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Millard, Michael A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What Do the Guidelines Really Say About Aspirin? |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.12.2018 | ||
| 500 | |a Date Revised 11.12.2018 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anticarcinogenic agents/therapeutic use | |
| 650 | 4 | |a aspirin/administration & dosage/adverse effects/therapeutic use | |
| 650 | 4 | |a cardiovascular diseases/prevention & control | |
| 650 | 4 | |a colorectal neoplasms/prevention & control | |
| 650 | 4 | |a hemorrhage/chemically induced | |
| 650 | 4 | |a practice guidelines as topic | |
| 650 | 4 | |a primary prevention/methods/standards | |
| 650 | 7 | |a Platelet Aggregation Inhibitors |2 NLM | |
| 650 | 7 | |a Aspirin |2 NLM | |
| 650 | 7 | |a R16CO5Y76E |2 NLM | |
| 700 | 1 | |a Hernandez-Vila, Eduardo A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Texas Heart Institute journal |d 1982 |g 45(2018), 4 vom: 29. Aug., Seite 228-230 |w (DE-627)NLM074901362 |x 1526-6702 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2018 |g number:4 |g day:29 |g month:08 |g pages:228-230 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.14503/THIJ-18-6673 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2018 |e 4 |b 29 |c 08 |h 228-230 | ||